纯塞式与以缝合为主血管闭合装置策略在经股动脉TAVR中的随机对照研究:CHOICE-CLOSURE试验
CHOICE-CLOSURE多中心随机试验纳入516例经股动脉TAVR患者,比较纯塞式(MANTA)与以缝合为主(ProGlide)血管闭合策略。主要终点为住院期间入路相关血管并发症,纯塞式组19.4%显著高于缝合组12.0%(RR 1.61,P=0.029),但止血时间更短。
要点
- 纯塞式组入路相关血管并发症发生率显著高于缝合组(19.4% vs 12.0%)。
- 两组入路相关出血和装置失败率无显著差异。
- 纯塞式组止血时间显著短于缝合组(80秒 vs 240秒)。
核心结论
- 经股动脉TAVR患者中,纯塞式MANTA血管闭合装置相比以缝合为主的ProGlide策略,入路相关血管并发症发生率更高,但止血时间更短。
研究设计与样本
- 研究者发起的多中心随机对照试验,共纳入516例接受经股动脉TAVR的患者,随机分配至纯塞式组(MANTA,n=258)或以缝合为主组(ProGlide,n=258)。
主要发现
- 主要终点(住院期间入路相关主要和次要血管并发症)纯塞式组为19.4%(50/258),缝合组为12.0%(31/258),RR 1.61(95%CI 1.07-2.44),P=0.029。
- 入路相关出血纯塞式组11.6%,缝合组7.4%,RR 1.58(95%CI 0.91-2.73),P=0.133。
- 装置失败纯塞式组4.7%,缝合组5.4%,RR 0.86(95%CI 0.40-1.82),P=0.841。
- 止血时间纯塞式组80(32-180)秒,缝合组240(174-316)秒,P<0.001。
关键数值与推荐
- 主要终点按VARC-2标准定义入路相关主要和次要血管并发症。
- 纯塞式技术使用MANTA装置且不附加其他血管闭合装置;以缝合为主技术使用ProGlide装置,可辅以小塞子。
临床怎么用
- 在经股动脉TAVR中选择血管闭合策略时,需权衡纯塞式MANTA止血更快但血管并发症风险更高的特点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement is an established treatment option for patients with severe symptomatic aortic stenosis and is most commonly performed through the transfemoral access route. Percutaneous access site closure can be achieved using dedicated plug-based or suture-based vascular closure device (VCD) strategies, but randomized comparative studies are scarce. METHODS: The CHOICE-CLOSURE trial (Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure during Transfemoral Transcatheter Aortic Valve Implantation) is an investigator-initiated, multicenter study, in which patients undergoing transfemoral transcatheter aortic valve replacement were randomly assigned to vascular access site closure using either a pure plug-based technique (MANTA, Teleflex) with no additional VCDs or a primary suture-based technique (ProGlide, Abbott Vascular) potentially complemented by a small plug. The primary end point consisted of access site- or access-related major and minor vascular complications during index hospitalization, defined according to the Valve Academic Research Consortium-2 criteria. Secondary end points included the rate of access site- or access-related bleeding, VCD failure, and time to hemostasis. RESULTS: A total of 516 patients were included and randomly assigned. The mean age of the study population was 80.5±6.1 years, 55.4% were male, 7.6% of patients had peripheral vascular disease, and the mean Society of Thoracic Surgeons score was 4.1±2.9%. The primary end point occurred in 19.4% (50/258) of the pure plug-based group and 12.0% (31/258) of the primary suture-based group (relative risk, 1.61 [95% CI, 1.07-2.44], P=0.029). Access site- or access-related bleeding occurred in 11.6% versus 7.4% (relative risk, 1.58 [95%CI: 0.91-2.73], P=0.133) and device failure in 4.7% versus 5.4% (relative risk, 0.86, [95% CI, 0.40-1.82], P=0.841) in the respective groups. Time to hemostasis was significantly shorter in the pure plug-based group (80 [32-180] versus 240 [174-316] seconds, P<0.001). CONCLUSIONS: Among patients treated with transfemoral transcatheter aortic valve replacement, a pure plug-based vascular closure technique using the MANTA VCD is associated with a higher rate of access site- or access-related vascular complications but a shorter time to hemostasis compared with a primary suture-based technique using the ProGlide VCD. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04459208.
引用
- Abdel-Wahab M, Hartung P, Dumpies O, et al. Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial. Circulation. 2021. PMID: 34738828. doi:10.1161/CIRCULATIONAHA.121.057856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。